论文部分内容阅读
目的评价贵州省跨区域流动肺结核患者治疗管理的情况,为完善全省流动人口肺结核患者管理策略提供参考。方法对贵州省2011-2014年上半年在“结核病管理信息系统”中登记的跨区域流动肺结核患者的基本情况、管理方式、到位情况和管理的效果进行分析,率的比较采用卡方检验,P<0.05为差异有统计学意义。结果贵州省2011-2014年上半年登记治疗的跨区域流动肺结核患者共1 411例,其中转出患者449例,转入患者962例;男性占66.41%、20~40岁的占72.22%,职业以农民、民工和工人为主,占71.79%,79.52%的患者需要跨省协作管理;转出患者的总体到位率(78.62%)、到位代管率(93.20%)均高于转入患者(分别为68.50%、86.80%,P值均<0.05);跨区域流动肺结核患者转诊未到位的主要原因为“未回(42.57%)、查无此人(15.11%)、外出(11.59%)”;转出代管患者的治疗成功率(80.55%)低于转入代管患者的治疗成功率(87.76%,P值<0.05)。结论《全国跨区域肺结核患者管理程序(试行)》的实施,为流动肺结核患者搭建了一个有效的管理平台,应进一步提高跨区域肺结核患者的治疗成功率,减少重新登记和丢失病人。
Objective To evaluate the treatment and management of mobile TB patients in Guizhou Province and to provide reference for improving the management strategies for TB patients in the floating population in Guizhou Province. Methods To analyze the basic situation, management methods, status and management effect of transboundary TB patients who registered in the Tuberculosis Management Information System in the first half of 2011-2014 in Guizhou Province. The rates were compared using the chi-square test , P <0.05 for the difference was statistically significant. Results A total of 1 411 cases of trans-regional TB cases registered for treatment in the first half of 2011-2014 in Guizhou Province were transferred out of 449 cases to 962 cases of patients, with 66.41% for males and 72.22% for 20-40 years of age The majority of peasants, migrant workers and workers accounted for 71.79%, 79.52% of the patients needed inter-provincial collaborative management. The overall delivery rate (78.62%) and the escrow rate (93.20%) in transferred patients were higher than those transferred to patients (42.57%), none (15.11%), 11.59% (15.9%) were out of bed, the difference was significant (P < ). The success rate of treatment (80.55%) was lower in escrow patients than that of patients in escrow (87.76%, P <0.05). Conclusions The implementation of the National Trans-Regional Tuberculosis Patient Management Program (Trial Implementation) has set an effective management platform for patients with mobile pulmonary tuberculosis, and should further improve the success rate of treatment for trans-regional tuberculosis patients and reduce the re-registration and loss of patients.